Low-dose tadalafil combined with Shuganyiyang capsules for mild-to-moderate erectile dysfunction

To observe the clinical effect of low-dose once-daily tadalafil combined with Shuganyiyang Capsules in the treatment of mild-to-moderate erectile dysfunction (ED). Ninety patients with mild-to-moderate ED were equally randomized to groups A, B and C to receive Shuganyiyang Capsules, tadalafil, and t...

Full description

Saved in:
Bibliographic Details
Published inZhonghua nan ke xue Vol. 20; no. 3; p. 267
Main Authors Yang, Ke-Bing, Huang, Xiao-Jun, Zhang, Shi-Geng, Chen, Gang, Fu, Jun, Lü, Bo-Dong
Format Journal Article
LanguageChinese
Published China 01.03.2014
Subjects
Adult
Carbolines - administration & dosage
Carbolines - therapeutic use
Drugs, Chinese Herbal - therapeutic use
Erectile Dysfunction - drug therapy
Humans
Male
Tadalafil
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:To observe the clinical effect of low-dose once-daily tadalafil combined with Shuganyiyang Capsules in the treatment of mild-to-moderate erectile dysfunction (ED). Ninety patients with mild-to-moderate ED were equally randomized to groups A, B and C to receive Shuganyiyang Capsules, tadalafil, and tadalafil + Shuganyiyang Capsules, respectively. The scores of the patients on IIEF-5 and SF-PAIRS (15-Item Short Form of Psychological Interpersonal Relationship Scales) were recorded before and at 1 and 3 months after treatment. The IIEF-5 scores of groups A, B and C were 10.13 +/- 1.55, 11.00 + 1.60 and 10.73 +/- 1.91 before treatment, and 13.77 +/- 2.11, 17.77 +/- 2.13 and 17.17 +/- 3.84 at 1 month after treatment, significantly higher in B and C than in A (P <0. 001) , but with no remarkable difference between B and C (P =0. 411). At 3 months after treatment, the IIEF-5 scores were 15.77 +/- 2.05, 18.07 +/- 2.24 and 19.37 +/- 3.76 in the three groups, dramatically higher in B and C than in A (P <0.001) as well
ISSN:1009-3591